首页 > 资讯 > Clinical reseach progress of long COVID

Clinical reseach progress of long COVID

泰然健康网
2024-12-19 04:33

[1] [2]

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. [DOI]

[3]

Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, Dodd JW, Maskell NA, Barratt SL. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort[J]. Thorax, 2021, 76(4): 399-401. [DOI]

[4]

Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation[J]. J Med Virol, 2021, 93(2): 1013-1022. [DOI]

[5]

Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, Zhang X, Shang L, Zhong J, Wang X, Wang J, Cao B. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study[J]. Lancet Respir Med, 2022, 10(9): 863-876. [DOI]

[6]

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study[J]. Lancet, 2021, 397(10270): 220-232. [DOI]

[7]

Kattainen S, Lindahl A, Vasankari T, Ollila H, Volmonen K, Piirilä P, Kauppi P, Paajanen J, Kreivi HR, Ulenius L, Varpula T, Aro M, Reijula J, Hästbacka J. Lung function and exercise capacity 6 months after hospital discharge for critical COVID-19[J]. BMC Pulm Med, 2022, 22(1): 243. [DOI]

[8]

Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, Baldon G, Bartolomei G, Battaglia M, Battistini S, Binda V, Borg M, Cantaluppi V, Castello LM, Clivati E, Cisari C, Costanzo M, Croce A, Cuneo D, De Benedittis C, De Vecchi S, Feggi A, Gai M, Gambaro E, Gattoni E, Gramaglia C, Grisafi L, Guerriero C, Hayden E, Jona A, Invernizzi M, Lorenzini L, Loreti L, Martelli M, Marzullo P, Matino E, Panero A, Parachini E, Patrucco F, Patti G, Pirovano A, Prosperini P, Quaglino R, Rigamonti C, Sainaghi PP, Vecchi C, Zecca E, Pirisi M. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge[J]. JAMA Netw Open, 2021, 4(1): e2036142. [DOI]

[9]

Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19[J]. Ann Intern Med, 2021, 174(4): 576-578. [DOI]

[10]

Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, Zhou X, Liu X, Huang X, Yuan S, Chen C, Gao F, Huang J, Shan H, Liu J. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase[J]. Respir Res, 2020, 21(1): 163. [DOI]

[11]

Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, Lei C, Chen R, Zhong N, Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge[J]. Eur Respir J, 2020, 55(6): 2001217. [DOI]

[12]

Shah AS, Wong AW, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, Carlsten C. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations[J]. Thorax, 2021, 76(4): 402-404. [DOI]

[13]

Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H, Gao YF, Xu AG. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery[J]. EClinicalMedicine, 2020, 25: 100463. [DOI]

[14]

Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, Liu H, Ewing RM, Jones MG, Hu Y, Nie H, Wang Y. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study[J]. Lancet Respir Med, 2021, 9(7): 747-754. [DOI]

[15]

Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study[J]. The Lancet Infect Dis, 2020, 20(4): 425-434. [DOI]

[16]

Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, Cui J, Xu W, Yang Y, Fayad ZA, Jacobi A, Li K, Li S, Shan H. CT imaging features of 2019 novel coronavirus (2019-nCoV)[J]. Radiology, 2020, 295(1): 202-207. [DOI]

[17]

Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, Li Y, Cao Y, Gu J, Wu H, Shi H. Six-month follow-up chest CT findings after severe COVID-19 pneumonia[J]. Radiology, 2021, 299(1): E177-E186. [DOI]

[18]

Ravaglia C, Doglioni C, Chilosi M, Piciucchi S, Dubini A, Rossi G, Pedica F, Puglisi S, Donati L, Tomassetti S, Poletti V. Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection[J]. Eur Respir J, 2022, 60(4): 2102411. [DOI]

[19]

Fabbri L, Moss S, Khan FA, Chi W, Xia J, Robinson K, Smyth AR, Jenkins G, Stewart I. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis[J]. Thorax, 2023, 78(2): 191-201. [DOI]

[20]

Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis[J]. Respir Res, 2022, 23(1): 233. [DOI]

[21]

Bhat RA, Maqbool S, Rathi A, Ali SM, Hussenbocus YAAM, Wentao X, Qu Y, Zhang Y, Sun Y, Fu HX, Wang LY, Dwivedi A, Bhat JA, Iqbal RS, Islam MM, Tibrewal A, Gao C. The effects of the SARS-CoV-2 virus on the cardiovascular system and coagulation state leading to cardiovascular diseases: a narrative review[J]. Inquiry, 2022, 59: 1438280126. [DOI]

[22]

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)[J]. JAMA Cardiol, 2020, 5(11): 1265-1273. [DOI]

[23]

Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19[J]. Nat Rev Cardiol, 2022, 19(5): 332-341. [DOI]

[24]

Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19[J]. Nat Med, 2022, 28(3): 583-590. [DOI]

[25]

Maiese A, Frati P, Del Duca F, Santoro P, Manetti AC, La Russa R, Di Paolo M, Turillazzi E, Fineschi V. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review[J]. Diagnostics (Basel), 2021, 11(9): 1647. [DOI]

[26]

Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss HP, Blankenberg S, Püschel K, Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases[J]. JAMA Cardiol, 2020, 5(11): 1281-1285. [DOI]

[27]

Philip B, Mukherjee P, Khare Y, Ramesh P, Zaidi S, Sabry H, Harky A. COVID-19 and its long-term impact on the cardiovascular system[J]. Expert Rev Cardiovasc Ther, 2023, 21(3): 211-218. [DOI]

[28]

Wen H, Gwathmey JK, Xie LH. Oxidative stress-mediated effects of angiotensin Ⅱ in the cardiovascular system[J]. World J Hypertens, 2012, 2(4): 34-44. [DOI]

[29]

Cenko E, Badimon L, Bugiardini R, Claeys MJ, De Luca G, de Wit C, Derumeaux G, Dorobantu M, Duncker DJ, Eringa EC, Gorog DA, Hassager C, Heinzel FR, Huber K, Manfrini O, Milicic D, Oikonomou E, Padro T, Trifunovic-Zamaklar D, Vasiljevic-Pokrajcic Z, Vavlukis M, Vilahur G, Tousoulis D. Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on thrombosis and the association for acute cardio vascular care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)[J]. Cardiovasc Res, 2021, 117(14): 2705-2729. [DOI]

[30]

Lassen MCH, Skaarup KG, Lind JN, Alhakak AS, Sengeløv M, Nielsen AB, Simonsen JØ, Johansen ND, Davidovski FS, Christensen J, Bundgaard H, Hassager C, Jabbari R, Carlsen J, Kirk O, Lindholm MG, Kristiansen OP, Nielsen OW, Ulrik CS, Sivapalan P, Gislason G, Møgelvang R, Jensen GB, Schnohr P, Søgaard P, Solomon SD, Iversen K, Jensen JUS, Schou M, Biering-Sørensen T. Recovery of cardiac function following COVID-19-ECHOVID-19: a prospective longitudinal cohort study[J]. Eur J Heart Fail, 2021, 23(11): 1903-1912. [DOI]

[31]

Patel UK, Mehta N, Patel A, Patel N, Ortiz JF, Khurana M, Urhoghide E, Parulekar A, Bhriguvanshi A, Patel N, Mistry AM, Patel R, Arumaithurai K, Shah S. Long-term neurological sequelae among severe COVID-19 patients: a systematic review and meta-analysis[J]. Cureus, 2022, 14(9): e29694. [DOI]

[32]

Beghi E, Giussani G, Westenberg E, Allegri R, Garcia-Azorin D, Guekht A, Frontera J, Kivipelto M, Mangialasche F, Mukaetova-Ladinska EB, Prasad K, Chowdhary N, Winkler AS. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions[J]. J Neurol, 2022, 269(5): 2265-2274. [DOI]

[33]

Estiri H, Strasser ZH, Brat GA, Semenov YR, Consortium for Characterization of COVID-19 by EHR (4CE), Patel CJ, Murphy SN. Evolving phenotypes of non-hospitalized patients that indicate long COVID[J]. BMC Med, 2021, 19(1): 249. [DOI]

[34]

Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19[J]. Nat Med, 2022, 28(11): 2406-2415. [DOI]

[35]

Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho SM. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis[J]. J Neurol Sci, 2022, 434: 120162. [DOI]

[36]

Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, Giannopoulos S, Tsiodras S, Gaga M, Tsivgoulis G. Neurological manifestations of long-COVID syndrome: a narrative review[J]. Ther Adv Chronic Dis, 2022, 13: 20406223221076890. [DOI]

[37]

Nersesjan V, Amiri M, Lebech AM, Roed C, Mens H, Russell L, Fonsmark L, Berntsen M, Sigurdsson ST, Carlsen J, Langkilde AR, Martens P, Lund EL, Hansen K, Jespersen B, Folke MN, Meden P, Hejl AM, Wamberg C, Benros ME, Kondziella D. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up[J]. J Neurol, 2021, 268(9): 3086-3104. [DOI]

[38]

Rass V, Beer R, Schiefecker AJ, Lindner A, Kofler M, Ianosi BA, Mahlknecht P, Heim B, Peball M, Carbone F, Limmert V, Kindl P, Putnina L, Fava E, Sahanic S, Sonnweber T, Löscher WN, Wanschitz JV, Zamarian L, Djamshidian A, Tancevski I, Weiss G, Bellmann-Weiler R, Kiechl S, Seppi K, Loeffler-Ragg J, Pfausler B, Helbok R. Neurological outcomes 1 year after COVID-19 diagnosis: a prospective longitudinal cohort study[J]. Eur J Neurol, 2022, 29(6): 1685-1696. [DOI]

[39]

Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho SM. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics[J]. Cells, 2023, 12(5): 816. [DOI]

[40]

Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay IC, Chou HJ, Fletcher RB, Das D, Street K, de Bezieux HR, Choi YG, Risso D, Dudoit S, Purdom E, Mill J, Hachem RA, Matsunami H, Logan DW, Goldstein BJ, Grubb MS, Ngai J, Datta SR. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia[J]. Sci Adv, 2020, 6(31): eabc5801. [DOI]

[41]

Heming M, Li X, Räuber S, Mausberg AK, Börsch AL, Hartlehnert M, Singhal A, Lu IN, Fleischer M, Szepanowski F, Witzke O, Brenner T, Dittmer U, Yosef N, Kleinschnitz C, Wiendl H, Stettner M, Meyer Zu Hörste G. Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid[J]. Immunity, 2021, 54(1): 164-175. [DOI]

[42]

Townsend L, Dyer AH, Naughton A, Kiersey R, Holden D, Gardiner M, Dowds J, O'Brien K, Bannan C, Nadarajan P, Dunne J, Martin-Loeches I, Fallon PG, Bergin C, O'Farrelly C, Cheallaigh CN, Bourke NM, Conlon N. Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health[J]. Front Immunol, 2021, 12: 676932. [DOI]

[43]

Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin[J]. Cardiovasc Diabetol, 2021, 20(1): 172. [DOI]

[44]

Zeng N, Zhao YM, Yan W, Li C, Lu QD, Liu L, Ni SY, Mei H, Yuan K, Shi L, Li P, Fan TT, Yuan JL, Vitiello MV, Kosten T, Kondratiuk AL, Sun HQ, Tang XD, Liu MY, Lalvani A, Shi J, Bao YP, Lu L. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action[J]. Mol Psychiatry, 2023, 28(1): 423-433. [DOI]

[45]

Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations[J]. Int J Clin Pract, 2021, 75(3): e13746. [DOI]

[46]

Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment[J]. CNS Drugs, 2022, 36(7): 681-702. [DOI]

[47]

Frontera, JA, Simon NM. Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19[J]. JAMA Psychiatry, 2022, 79(8): 811-817. [DOI]

[48]

Landstra CP, de Koning EJP. COVID-19 and diabetes: understanding the interrelationship and risks for a severe course[J]. Front Endocrinol (Lausanne), 2021, 12: 649525. [DOI]

[49]

Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes[J]. Acta Diabetol, 2010, 47(3): 193-199. [DOI]

[50]

Brix TH, Hegedus L, Hallas J, Lund LC. Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism[J]. Lancet Diabetes Endocrinol, 2021, 9(4): 197-199. [DOI]

[51]

Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, Chen X, Ren H, Sun R, Liu W, Liu X, Liu C, Li A, Wang X, Rao B, Yuan C, Zhang H, Sun J, Chen X, Li B, Hu C, Wu Z, Yu Z, Kan Q, Li L. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19[J]. Gut, 2021, 70(7): 1253-1265. [DOI]

[52]

Sorokin AV, Karathanasis SK, Yang ZH, Freeman L, Kotani K, Remaley AT. COVID-19-associated dyslipidemia: implications for mechanism of impaired resolution and novel therapeutic approaches[J]. FASEB J, 2020, 34(8): 9843-9853. [DOI]

[53] [54]

Deuel JW, Lauria E, Lovey T, Zweifel S, Meier MI, Züst R, Gültekin N, Stettbacher A, Schlagenhauf P. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss armed forces: a longitudinal, cohort study (LoCoMo)[J]. Lancet Infect Dis, 2022, 22(12): 1694-1702. [DOI]

[55]

Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, Shah AD, Singh M, Kidy F, Okoth K, Hotham R, Bashir N, Cockburn N, Lee SI, Turner GM, Gkoutos GV, Aiyegbusi OL, McMullan C, Denniston AK, Sapey E, Lord JM, Wraith DC, Leggett E, Iles C, Marshall T, Price MJ, Marwaha S, Davies EH, Jackson LJ, Matthews KL, Camaradou J, Calvert M, Haroon S. Symptoms and risk factors for long COVID in non-hospitalized adults[J]. Nat Med, 2022, 28(8): 1706-1714. [DOI]

[56]

Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, Jacobs ET, Farland LV. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study[J]. Am J Obstet Gynecol, 2022, 226(2): 270-273. [DOI]

[57]

Nugent J, Aklilu A, Yamamoto Y, Simonov M, Li F, Biswas A, Ghazi L, Greenberg H, Mansour G, Moledina G, Wilson FP. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19[J]. JAMA Netw Open, 2021, 4(3): e211095. [DOI]

[58]

Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID[J]. J Am Soc Nephrol, 2021, 32(11): 2851-2862. [DOI]

[59]

Chand S, Kapoor S, Naqvi A, Thakkar J, Fazzari MJ, Orsi D, Dieiev V, Lewandowski DC, Dicpinigaitis PV. Long-term follow up of renal and other acute organ failure in survivors of critical illness due to Covid-19[J]. J Intensive Care Med, 2022, 37(6): 736-742. [DOI]

[60]

Chiang KC, Imig JD, Kalantar-Zadeh K, Gupta A. Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis[J]. Curr Opin Nephrol Hypertens, 2022, 31(1): 36-46. [DOI]

[61]

Meringer H, Mehandru S. Gastrointestinal post-acute COVID-19 syndrome[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(6): 345-346. [DOI]

[62]

Hajifathalian K, Krisko T, Mehta A, Kumar S, Schwartz R, Fortune B, Sharaiha RZ, WCM-GI research group. Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: clinical implications[J]. Gastroenterology, 2020, 159(3): 1137-1140. [DOI]

[63]

Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms[J]. Gastroenterology, 2022, 162(2): 648-650. [DOI]

[64]

Aleem A, Shah H. Gastrointestinal and hepatic manifestations of coronavirus (COVID-19)[M]. Treasure Island, FL: StatPearls Publishing, 2023.

[65]

Vodnar DC, Mitrea L, Teleky BE, Szabo K, Cǎlinoiu LF, Nemes SA, Martǎu GA. Coronavirus disease (COVID-19) caused by (SARS-CoV-2) infections: a real challenge for human gut microbiota[J]. Front Cell Infect Microbiol, 2020, 10: 575559. [DOI]

[66]

Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections[J]. Liver Int, 2020, 40(5): 998-1004. [DOI]

[67]

Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K, Chen H, Zeng Z, Qin Y, Wang H, Xing M, Xu D, Li W, Ni M, Zhu L, Chen L, Chen G, Qi W, Wu T, Yu H, Huang J, Han M, Zhu W, Guo W, Luo X, Chen T, Ning Q. Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China[J]. Clin Infect Dis, 2022, 74(11): 1953-1965. [DOI]

[68]

Liao X, Li D, Ma Z, Zhang L, Zheng B, Li Z, Li G, Liu L, Zhang Z. 12-month post-discharge liver function test abnormalities among patients with COVID-19: a single-center prospective cohort study[J]. Front Cell Infect Microbiol, 2022, 12: 864933. [DOI]

[69]

Katsoularis I, Fonseca-Rodriguez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, Lindmark K, Fors Connolly AM. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study[J]. BMJ, 2022, 377: e69590. [DOI]

[70]

Jiménez-Rodríguez BM, Gutiérrez-Fernández J, Ramos-Urbina EM, Romero-Ortiz AD, García-Flores PI, Santiago-Puertas MI, Martín-López MJ, López-Milena G, Fabregas R, Morales-García C. On the single and multiple associations of COVID-19 post-acute sequelae: 6-month prospective cohort study[J]. Sci Rep, 2022, 12(1): 3402. [DOI]

[71]

Knight R, Walker V, Ip S, Cooper JA, Bolton T, Keene S, Denholm R, Akbari A, Abbasizanjani H, Torabi F, Omigie E, Hollings S, North TL, Toms R, Jiang X, Angelantonio ED, Denaxas S, Thygesen JH, Tomlinson C, Bray B, Smith CJ, Barber M, Khunti K, Davey Smith G, Chaturvedi N, Sudlow C, Whiteley WN, Wood AM, Sterne JAC, CVD-COVID-UK/COVID-IMPACT Consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales[J]. Circulation, 2022, 146(12): 892-906. [DOI]

[72]

de Roquetaillade C, Chousterman B G, Tomasoni D, Zeitouni M, Houdart E, Guedon A, Reiner P, Bordier R, Gayat E, Montalescot G, Metra M, Mebazaa A. Unusual arterial thrombotic events in Covid-19 patients[J]. Int J Cardiol, 2021, 323: 281-284. [DOI]

[73]

Azouz E, Yang S, Monnier-Cholley L, Arrivé L. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19[J]. Intensive Care Med, 2020, 46(7): 1464-1465. [DOI]

[74]

Parry AH, Wani AH, Yaseen M. Acute mesenteric ischemia in severe coronavirus-19 (COVID-19): possible mechanisms and diagnostic pathway[J]. Acad Radiol, 2020, 27(8): 1190. [DOI]

[75]

Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S, Fan Z, Dong J, Yuan Z, Ding Z, Zhang Y, Hu L. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19[J]. J Hematol Oncol, 2020, 13(1): 120. [DOI]

[76]

Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, Scott JT, O'Donnell CA, Blane DN, Browne S, Ibbotson TR, Pell JP. Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study[J]. Nat Commun, 2022, 13(1): 5663. [DOI]

[77]

Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, Blyuss O, Bobkova P, Bonsel G, Borzakova S, Buonsenso D, Butnaru D, Carter A, Chu H, De Rose C, Diab MM, Ekbom E, El Tantawi M, Fomin V, Frithiof R, Gamirova A, Glybochko PV, Haagsma JA, Haghjooy Javanmard S, Hamilton EB, Harris G, Heijenbrok-Kal MH, Helbok R, Hellemons ME, Hillus D, Huijts SM, Hultström M, Jassat W, Kurth F, Larsson IM, Lipcsey M, Liu C, Loflin CD, Malinovschi A, Mao W, Mazankova L, McCulloch D, Menges D, Mohammadifard N, Munblit D, Nekliudov NA, Ogbuoji O, Osmanov IM, Peñalvo JL, Petersen MS, Puhan MA, Rahman M, Rass V, Reinig N, Ribbers GM, Ricchiuto A, Rubertsson S, Samitova E, Sarrafzadegan N, Shikhaleva A, Simpson KE, Sinatti D, Soriano JB, Spiridonova E, Steinbeis F, Svistunov AA, Valentini P, van de Water BJ, van den Berg-Emons R, Wallin E, Witzenrath M, Wu Y, Xu H, Zoller T, Adolph C, Albright J, Amlag JO, Aravkin AY, Bang-Jensen BL, Bisignano C, Castellano R, Castro E, Chakrabarti S, Collins JK, Dai X, Daoud F, Dapper C, Deen A, Duncan BB, Erickson M, Ewald SB, Ferrari AJ, Flaxman AD, Fullman N, Gamkrelidze A, Giles JR, Guo G, Hay SI, He J, Helak M, Hulland EN, Kereselidze M, Krohn KJ, Lazzar-Atwood A, Lindstrom A, Lozano R, Malta DC, Månsson J, Mantilla Herrera AM, Mokdad AH, Monasta L, Nomura S, Pasovic M, Pigott DM, Reiner RC Jr, Reinke G, Ribeiro ALP, Santomauro DF, Sholokhov A, Spurlock EE, Walcott R, Walker A, Wiysonge CS, Zheng P, Bettger JP, Murray CJL, Vos T. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021[J]. JAMA, 2022, 328(16): 1604-1615. [DOI]

[78]

Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ, Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 viral load is associated with increased disease severity and mortality[J]. Nat Commun, 2020, 11(1): 5493. [DOI]

[79]

中国抗癌协会肿瘤支持治疗专业委员会, 中国抗癌协会肿瘤临床化疗专业委员会. 新型冠状病毒肺炎疫情期间实体肿瘤患者防护和诊治管理相关问题中国专家共识(2022版)[J]. 中华肿瘤杂志, 2022, 44(10): 1083-1090.

[80]

Sumi T, Harada K. Immune response to SARS-CoV-2 in severe disease and long COVID-19[J]. iScience, 2022, 25(8): 104723. [DOI]

[81]

Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, ISB-Swedish COVID-19 Biobanking Unit, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Multiple early factors anticipate post-acute COVID-19 sequelae[J]. Cell, 2022, 185(5): 881-895. [DOI]

[82]

Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection[J]. Nat Med, 2022, 28(11): 2398-2405. [DOI]

[83]

Jaramillo M, Thyvalikakath TP, Eckert G, Srinivasan M. Characteristics of chemosensory perception in long COVID and COVID reinfection[J]. J Clin Med, 2023, 12(10): 3598. [DOI]

[84]

Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, Walker TA, Selvaggi CA, Shinnick DJ, Schulte CCM, Atchley-Challenner R, Alba GA, Alicic R, Altman N, Anglin K, Argueta U, Ashktorab H, Baslet G, Bassett IV, Bateman L, Bedi B, Bhattacharyya S, Bind MA, Blomkalns AL, Bonilla H, Bush PA, Castro M, Chan J, Charney AW, Chen P, Chibnik LB, Chu HY, Clifton RG, Costantine MM, Cribbs SK, Davila Nieves SI, Deeks SG, Duven A, Emery IF, Erdmann N, Erlandson KM, Ernst KC, Farah-Abraham R, Farner CE, Feuerriegel EM, Fleurimont J, Fonseca V, Franko N, Gainer V, Gander JC, Gardner EM, Geng LN, Gibson KS, Go M, Goldman JD, Grebe H, Greenway FL, Habli M, Hafner J, Han JE, Hanson KA, Heath J, Hernandez C, Hess R, Hodder SL, Hoffman MK, Hoover SE, Huang B, Hughes BL, Jagannathan P, John J, Jordan MR, Katz SD, Kaufman ES, Kelly JD, Kelly SW, Kemp MM, Kirwan JP, Klein JD, Knox KS, Krishnan JA, Kumar A, Laiyemo AO, Lambert AA, Lanca M, Lee-Iannotti JK, Logarbo BP, Longo MT, Luciano CA, Lutrick K, Maley JH, Marathe JG, Marconi V, Marshall GD, Martin CF, Matusov Y, Mehari A, Mendez-Figueroa H, Mermelstein R, Metz TD, Morse R, Mosier J, Mouchati C, Mullington J, Murphy SN, Neuman RB, Nikolich JZ, Ofotokun I, Ojemakinde E, Palatnik A, Palomares K, Parimon T, Parry S, Patterson JE, Patterson TF, Patzer RE, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Quigley JG, Reddy U, Reece R, Reeder H, Reeves WB, Reiman EM, Rischard F, Rosand J, Rouse DJ, Ruff A, Saade G, Sandoval GJ, Schlater SM, Shepherd F, Sherif ZA, Simhan H, Singer NG, Skupski DW, Sowles A, Sparks JA, Sukhera FI, Taylor BS, Teunis L, Thomas RJ, Thorp JM, Thuluvath P, Ticotsky A, Tita AT, Tuttle KR, Urdaneta AE, Valdivieso D, VanWagoner TM, Vasey A, Verduzco-Gutierrez M, Wallace ZS, Ward HD, Warren DE, Weiner SJ, Welch S, Whiteheart SW, Wiley Z, Wisnivesky JP, Yee LM, Zisis S, Horwitz LI, Foulkes AS, RECOVER Consortium. Development of a definition of postacute sequelae of SARS-CoV-2 infection[J]. JAMA, 2023, 329(22): 1934-1946. [DOI]

[85]

郭香蕊, 钱力, 刘学军. 肺康复对特发性肺纤维化病人心肺功能及生活质量影响的Meta分析[J]. 护理研究, 2023, 37(1): 169-173. [CNKI]

[86]

Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease[J]. Thorax, 2008, 63(6): 549-554. [DOI]

[87]

李智慧, 邸家琪, 徐莉莉, 杨曙光, 于宁霞, 余学庆. 康复疗法干预特发性肺纤维化的临床研究现状及特征分析[J]. 世界科学技术-中医药现代化, 2023, 25(2): 694-701. [CNKI]

[88]

倪晓琴, 张海霞, 折艳涛. 自拟补气通络方联合情绪释放疗法在气虚血瘀型肺纤维化患者中的应用评价[J]. 四川中医, 2019, 37(2): 85-87. [CNKI]

[89]

李戎, 闫智勇, 李文军, 刘春涛, 田和炳, 李艳华, 刘宗群, 任玉兰, 李富红. 针灸治疗特发性肺纤维化临床观察[J]. 针灸临床杂志, 2004, 20(2): 11-12. [CNKI]